Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Recruiting in Palo Alto (17 mi)

+51 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

No Placebo Group

Trial Summary

What is the purpose of this trial?

This study is designed to assess the safety of Mylotarg therapy in routine practice.

Eligibility Criteria

Inclusion Criteria

Treated by Mylotarg

Provide IC

Treatment Details

Interventions

• Mylotarg (Gemtuzumab Ozogamicin) (Monoclonal Antibodies)

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

NCT00161668 Chicago, IL

NCT00161668 Kalamazoo, MI

NCT00161668 Columbia, MO

NCT00161668 Bronx, NY

More Trial Locations

Who Is Running the Clinical Trial?

Wyeth is now a wholly owned subsidiary of Pfizer Lead Sponsor

References